TETRAPHASE PHARMACEUTICALS I's ticker is TTPHXXXX and the CUSIP is 88165N105. A total of 66 filers reported holding TETRAPHASE PHARMACEUTICALS I in Q2 2014. The put-call ratio across all filers is 0.51 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $124,000 | -75.7% | 109,800 | -40.6% | 0.00% | -60.0% |
| Q3 2018 | $510,000 | +78.9% | 184,800 | +131.6% | 0.01% | +66.7% |
| Q2 2018 | $285,000 | +16.3% | 79,800 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $245,000 | -51.3% | 79,800 | 0.0% | 0.00% | -40.0% |
| Q4 2017 | $503,000 | -7.9% | 79,800 | 0.0% | 0.01% | -16.7% |
| Q3 2017 | $546,000 | -4.0% | 79,800 | 0.0% | 0.01% | -14.3% |
| Q2 2017 | $569,000 | -60.0% | 79,800 | -48.4% | 0.01% | -58.8% |
| Q1 2017 | $1,423,000 | +25.7% | 154,800 | -44.9% | 0.02% | +13.3% |
| Q4 2016 | $1,132,000 | +5.2% | 280,900 | 0.0% | 0.02% | -6.2% |
| Q3 2016 | $1,076,000 | -30.8% | 280,900 | -22.3% | 0.02% | -33.3% |
| Q2 2016 | $1,555,000 | +29.0% | 361,717 | +1324.1% | 0.02% | 0.0% |
| Q2 2015 | $1,205,000 | -34.2% | 25,400 | -49.2% | 0.02% | -36.8% |
| Q1 2015 | $1,832,000 | -7.8% | 50,000 | 0.0% | 0.04% | -15.6% |
| Q4 2014 | $1,986,000 | +99.0% | 50,000 | 0.0% | 0.04% | +80.0% |
| Q3 2014 | $998,000 | +47.9% | 50,000 | 0.0% | 0.02% | +38.9% |
| Q2 2014 | $675,000 | – | 50,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 330,000 | $2,353,000 | 0.98% |
| EcoR1 Capital, LLC | 633,400 | $4,516,000 | 0.80% |
| DLD Asset Management, LP | 570,000 | $4,059,000 | 0.53% |
| Rhenman & Partners Asset Management AB | 300,000 | $2,139,000 | 0.31% |
| Eventide Asset Management | 600,000 | $4,278,000 | 0.27% |
| Tekla Capital Management LLC | 1,004,322 | $7,161,000 | 0.26% |
| Rock Springs Capital Management LP | 698,000 | $4,977,000 | 0.25% |
| DLD Asset Management, LP | 230,000 | $1,640,000 | 0.21% |
| Worth Venture Partners, LLC | 29,325 | $209,000 | 0.18% |
| Crestline Management, LP | 161,403 | $1,151,000 | 0.15% |